Mega-Thread on Dilip Shantilal Shanghvi, owner of India's most valuable listed pharma company @SunPharma_Live
Would appreciate a Retweet as it helps us educate more investors and inspire us to work harder on more threads
Would appreciate a Retweet as it helps us educate more investors and inspire us to work harder on more threads
1)Dilip Shantilal Shanghvi, was born in Amreli, Gujarat, in 1955.
2)Following his graduation in 1982, from the University of Calcutta with a bachelor's degree in commerce, Dilip Shanghvi launched Sun Pharma.
2)Following his graduation in 1982, from the University of Calcutta with a bachelor's degree in commerce, Dilip Shanghvi launched Sun Pharma.
3)Dilip Sanghvi established Sun Pharmaceuticals as a partnership firm with Pradeep GhoshFounded in 1983 with a capital of Rs. 10,000 and just one pharmaceutical product
4)By 1990, Sun Pharmaceutical Industries Ltd had its own manufacturing and research facilities, and its cardiology and gastroenterology product lines had been added.
5)In 1994, Dilip Shanghvi went public with Sun Pharmaceuticals Ltd.
5)In 1994, Dilip Shanghvi went public with Sun Pharmaceuticals Ltd.
6)With its 1997 acquisition of Detroit-based Caraco Pharmaceutical Laboratories, Sun Pharma made its first international acquisition.
7)Initially, Dilip Sanghvi worked for his father in his wholesale generic drugs business in Kolkata.
7)Initially, Dilip Sanghvi worked for his father in his wholesale generic drugs business in Kolkata.
8)While working for a drugs distributor at Kolkata, he figured it would be more lucrative to manufacture drugs than sell others' products.
9)Most of the company's business comes from markets outside India, primarily from the US, which represents around 60% of the revenues.
9)Most of the company's business comes from markets outside India, primarily from the US, which represents around 60% of the revenues.
10)The Sun Pharmaceuticals company has manufacturing plants in more than 20 countries, including the US, Canada, Brazil, Mexico, and Israel.
11) Dilip Sanghvi's Sun Pharmaceuticals has a revenue of $5 billion, making it India's most valuable listed pharma company.
11) Dilip Sanghvi's Sun Pharmaceuticals has a revenue of $5 billion, making it India's most valuable listed pharma company.
12)As Dilip Shanghvi led Sun Pharmaceutical, it grew rapidly and acquired more than a dozen brands and companies between 1999 and 2012.
13)In 2012, After Dilip Shanghvi stepped down as Chairman and CEO of Teva Pharmaceuticals, Israel Makov came forward as his successor.
13)In 2012, After Dilip Shanghvi stepped down as Chairman and CEO of Teva Pharmaceuticals, Israel Makov came forward as his successor.
14)Dilip Sanghvi led the company through a series of acquisitions including the $4 billion purchase of scandal-tainted Ranbaxy Laboratories in 2014.
15)In addition to his investments in pharmaceuticals, Dilip Shanghvi also showed an increasing interest in renewable energy.
15)In addition to his investments in pharmaceuticals, Dilip Shanghvi also showed an increasing interest in renewable energy.
16)As a result of the soaring stock price of Dilip Sanghavi's parent company, he surpassed Mukesh Ambani to become the wealthiest person in India in 2015.
17)In 2016, Dilip Sanghvi was awarded a Padma Shri by the Government of India.
17)In 2016, Dilip Sanghvi was awarded a Padma Shri by the Government of India.
18)In 2017, he was named the 8th most influential person by India Today magazine.
19)In 2019, the decline of Sun Pharma cost Dilip Shanghvi a big chunk of his wealth of about 60 %.
19)In 2019, the decline of Sun Pharma cost Dilip Shanghvi a big chunk of his wealth of about 60 %.
20)In 2019, Sun Pharma's Halol plant faced a recall for manufacturing lapses by the US Food and Drug Administration, leading to the company's financial collapse.
21)With Taro’s acquisition, Sun can tap the customer potential in Canada along with other foreign markets.
21)With Taro’s acquisition, Sun can tap the customer potential in Canada along with other foreign markets.
22)In 2011, he was presented with the ‘CNN-IBN Indian of the Year’ in the business category and was awarded the JRD TATA Corporate Leadership Award by AIMA.
24)Awarded as World Entrepreneur of the Year by E&Y (2011) & Awarded as First Generation Entrepreneur by CNBC TV.
24)Awarded as World Entrepreneur of the Year by E&Y (2011) & Awarded as First Generation Entrepreneur by CNBC TV.
25)He is married to Vibha Sanghvi. The couple has a son, Aalok, and daughter Vidhi from their marriage. Both of whom are currently working in Sun Pharmaceuticals.
26)Dilip Shanghvi has an estimated net worth of more than $10 billion.
26)Dilip Shanghvi has an estimated net worth of more than $10 billion.
27)In 2019, journalist Soma Das authored The Reluctant Billionaire, the first and only biography of Dilip Shanghvi. Published by Penguin Random House, the book was nominated for Tata Literature Award in the Best Business Book category in November 2019.
28)In 2018, Dilip Sanghavi was one of thе mеmbеrѕ оf RВІ’ѕ роwеrful grоuр оf 21 mеmbеrѕ central bоаrd соmmіttее bу thе government of Іndіа.
Would appreciate a retweet as that inspires us to educate more investors and work harder on upcoming threads.
Would appreciate a retweet as that inspires us to educate more investors and work harder on upcoming threads.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
